1. Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms
   Bruna Prunes Pena Baroni Viana et al, 2021, Biomedicines CrossRef
2. HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer
   Tian Wang et al, 2022, Disease Markers CrossRef
3. Aging‑associated genes TNFRSF12A and CHI3L1 contribute to thyroid cancer: An evidence for the involvement of hypoxia as a driver
   Meng Lian et al, 2020, Oncology Letters CrossRef
4. Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1
   Jia Xie et al, 2021, Journal of Immunology Research CrossRef
5. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT
   Xing Chang et al, 2023, Biochemical Pharmacology CrossRef
6. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs
   Li Zhang et al, 2022, Frontiers in Oncology CrossRef
7. Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling–Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors
   Dong Wang et al, 2024, Cancer Research CrossRef
8. Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor
   Eusebio Chiefari et al, 2018, Frontiers in Endocrinology CrossRef
9. Association between the methylation of six apoptosis‑associated genes with autism spectrum disorder
   Yuanzhi Zhao et al, 2018, Molecular Medicine Reports CrossRef
10. miR‑638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells
    Li Ma et al, 2021, Experimental and Therapeutic Medicine CrossRef
11. Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
    Marika H Tesselaar et al, 2017, Journal of Molecular Endocrinology CrossRef
12. High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer
    Hung-Pin Chang et al, 2022, Life CrossRef
13. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma
    Nan Zhang et al, 2019, Cancer Biomarkers CrossRef
14. IL‑17 induces NSCLC A549 cell proliferation via the upregulation of HMGA1, resulting in an increased cyclin D1 expression
    Chenhui Zhao et al, 2018, International Journal of Oncology CrossRef
15. Assessment of the TGFB1 gene expression and methylation status of the promoter region in patients with colorectal cancer
    Damian Wodziński et al, 2022, Scientific Reports CrossRef
16. Impact of transforming growth factor beta 1 on normal and thyroid cancer side population cells
    Nani Md Latar et al, 2022, Endocrine CrossRef
17. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling
    Zhi-Gao Hu et al, 2020, Life Sciences CrossRef
18. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
    Heewa Shakib et al, 2019, Endocrine CrossRef
19. RNA binding protein HuR promotes osteosarcoma cell progression via suppressing the miR‑142‑3p/HMGA1 axis
    Weicheng Pan et al, 2018, Oncology Letters CrossRef
20. HMGA1 in cancer: Cancer classification by location
    Yuhong Wang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
21. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients
    Terrick Andey et al, 2020, Gene CrossRef
22. The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
    Monica Fedele et al, 2022, International Journal of Molecular Sciences CrossRef